Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

Patrizia Nanni, Giordano Nicoletti, Arianna Palladini, Stefania Croci, Annalisa Murgo, Marianna L. Ianzano, Valentina Grosso, Valeria Stivani, Agnese Antognoli, Alessia Lamolinara, Lorena Landuzzi, Emmanuelle di Tomaso, Manuela Iezzi, Carla de Giovanni, Pier Luigi Lollini

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2-/-;Il2rg-/-, which lacks T, B and NK cell activity. In this model human metastatic HER-2+ breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2+ breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2-/-;Il2rg-/- mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2+ breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2-/-; Il2rg-/- mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2+ human breast cancer cells in Rag2-/-;Il2rg-/- mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.

Original languageEnglish
Article numbere39626
JournalPLoS One
Volume7
Issue number6
DOIs
Publication statusPublished - Jun 21 2012

Fingerprint

phosphatidylinositol 3-kinase
Phosphatidylinositol 3-Kinases
metastasis
breast neoplasms
Cells
Breast Neoplasms
Neoplasm Metastasis
Tumors
Brain
mice
Bone
blood-brain barrier
Blood-Brain Barrier
brain
neoplasms
Liver
Bone and Bones
cell lines
Neoplasms
bones

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor. / Nanni, Patrizia; Nicoletti, Giordano; Palladini, Arianna; Croci, Stefania; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Antognoli, Agnese; Lamolinara, Alessia; Landuzzi, Lorena; di Tomaso, Emmanuelle; Iezzi, Manuela; de Giovanni, Carla; Lollini, Pier Luigi.

In: PLoS One, Vol. 7, No. 6, e39626, 21.06.2012.

Research output: Contribution to journalArticle

Nanni, P, Nicoletti, G, Palladini, A, Croci, S, Murgo, A, Ianzano, ML, Grosso, V, Stivani, V, Antognoli, A, Lamolinara, A, Landuzzi, L, di Tomaso, E, Iezzi, M, de Giovanni, C & Lollini, PL 2012, 'Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor', PLoS One, vol. 7, no. 6, e39626. https://doi.org/10.1371/journal.pone.0039626
Nanni, Patrizia ; Nicoletti, Giordano ; Palladini, Arianna ; Croci, Stefania ; Murgo, Annalisa ; Ianzano, Marianna L. ; Grosso, Valentina ; Stivani, Valeria ; Antognoli, Agnese ; Lamolinara, Alessia ; Landuzzi, Lorena ; di Tomaso, Emmanuelle ; Iezzi, Manuela ; de Giovanni, Carla ; Lollini, Pier Luigi. / Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor. In: PLoS One. 2012 ; Vol. 7, No. 6.
@article{6c87484852c04e0993175a70fcc5340f,
title = "Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor",
abstract = "In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2-/-;Il2rg-/-, which lacks T, B and NK cell activity. In this model human metastatic HER-2+ breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2+ breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2-/-;Il2rg-/- mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2+ breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2-/-; Il2rg-/- mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2+ human breast cancer cells in Rag2-/-;Il2rg-/- mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.",
author = "Patrizia Nanni and Giordano Nicoletti and Arianna Palladini and Stefania Croci and Annalisa Murgo and Ianzano, {Marianna L.} and Valentina Grosso and Valeria Stivani and Agnese Antognoli and Alessia Lamolinara and Lorena Landuzzi and {di Tomaso}, Emmanuelle and Manuela Iezzi and {de Giovanni}, Carla and Lollini, {Pier Luigi}",
year = "2012",
month = "6",
day = "21",
doi = "10.1371/journal.pone.0039626",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

AU - Nanni, Patrizia

AU - Nicoletti, Giordano

AU - Palladini, Arianna

AU - Croci, Stefania

AU - Murgo, Annalisa

AU - Ianzano, Marianna L.

AU - Grosso, Valentina

AU - Stivani, Valeria

AU - Antognoli, Agnese

AU - Lamolinara, Alessia

AU - Landuzzi, Lorena

AU - di Tomaso, Emmanuelle

AU - Iezzi, Manuela

AU - de Giovanni, Carla

AU - Lollini, Pier Luigi

PY - 2012/6/21

Y1 - 2012/6/21

N2 - In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2-/-;Il2rg-/-, which lacks T, B and NK cell activity. In this model human metastatic HER-2+ breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2+ breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2-/-;Il2rg-/- mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2+ breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2-/-; Il2rg-/- mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2+ human breast cancer cells in Rag2-/-;Il2rg-/- mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.

AB - In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2-/-;Il2rg-/-, which lacks T, B and NK cell activity. In this model human metastatic HER-2+ breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2+ breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2-/-;Il2rg-/- mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2+ breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2-/-; Il2rg-/- mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2+ human breast cancer cells in Rag2-/-;Il2rg-/- mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.

UR - http://www.scopus.com/inward/record.url?scp=84862649113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862649113&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0039626

DO - 10.1371/journal.pone.0039626

M3 - Article

C2 - 22737248

AN - SCOPUS:84862649113

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e39626

ER -